SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hy… Read more
SeaStar Medical Holding Corporation (ICU) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.335x
Based on the latest financial reports, SeaStar Medical Holding Corporation (ICU) has a cash flow conversion efficiency ratio of -0.335x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.84 Million) by net assets ($11.46 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
SeaStar Medical Holding Corporation - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how SeaStar Medical Holding Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
SeaStar Medical Holding Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SeaStar Medical Holding Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shreyans Industries Limited
NSE:SHREYANIND
|
0.039x |
|
VVT Med Inc.
V:VVTM
|
3.168x |
|
BMC
ST:BMC
|
0.337x |
|
Minda Global Bhd
KLSE:5166
|
0.012x |
|
Addex Therapeutics Ltd
NASDAQ:ADXN
|
-0.089x |
|
Tong Herr Resources Bhd
KLSE:5010
|
0.061x |
|
EarthRenew Inc
PINK:VVIVF
|
-0.023x |
|
Kalyani Forge Limited
NSE:KALYANIFRG
|
-0.027x |
Annual Cash Flow Conversion Efficiency for SeaStar Medical Holding Corporation (2020–2024)
The table below shows the annual cash flow conversion efficiency of SeaStar Medical Holding Corporation from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-2.18 Million | $-16.01 Million | 7.333x | +888.85% |
| 2023-12-31 | $-13.87 Million | $-10.29 Million | 0.742x | +97.53% |
| 2022-12-31 | $-20.76 Million | $-7.79 Million | 0.375x | -79.33% |
| 2021-12-31 | $-2.82 Million | $-5.11 Million | 1.816x | +2233.07% |
| 2020-12-31 | $-71.58 Million | $-5.57 Million | 0.078x | -- |